多参数磁共振成像检测临床显著前列腺癌:泌尿外科医生需知。第4部分:局部麻醉下经会阴磁共振-超声融合引导穿刺活检
这项单中心前瞻性队列研究纳入2015年11月至2020年11月连续1097例疑似前列腺癌的初诊男性,PI-RADS v2评分3-5分者接受局部麻醉下经会阴磁共振-超声融合引导穿刺活检。并发症率0.73%,无预防性抗生素使用下感染性并发症可忽略,66%检出GG≥2前列腺癌,活检耐受性良好。
要点
- 局部麻醉下经会阴融合活检并发症率0.73%(8/1097),感染性并发症0.46%。
- 1097例中66%(723例)检出GG≥2前列腺癌,19%(203例)检出GG1。
- 局部麻醉和活检过程中位疼痛评分分别为2分和1分,耐受性良好。
核心结论
- 经会阴磁共振-超声融合引导穿刺活检可在门诊局部麻醉下安全进行,无需预防性抗生素,临床显著前列腺癌检出率高且耐受性良好。
研究设计与样本
- 单中心前瞻性数据库研究,2015年11月至2020年11月连续纳入1097例疑似前列腺癌的初诊男性,PI-RADS v2评分3-5分者接受局部麻醉下经会阴磁共振-超声融合引导穿刺活检。
主要发现
- 并发症率为0.73%(8/1097),包括5例(0.46%)尿路感染(其中1例住院)和3例(0.27%)尿潴留。
- 735例中,局部麻醉过程中位疼痛评分为2分(IQR 2-3),活检过程中位疼痛评分为1分(IQR 0-2)。
- 1097例中84%(926例)检出前列腺癌,66%(723例)为GG≥2,19%(203例)为GG1。
临床怎么用
- 作者认为经会阴磁共振-超声融合引导穿刺活检可在门诊局部麻醉下安全实施,无需预防性抗生素,感染性并发症率可忽略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transperineal magnetic resonance imaging-transrectal ultrasound fusion guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of biopsy-related infections. However, its widespread implementation has been hampered by the supposed necessity of epidural or general anesthesia. OBJECTIVE: To demonstrate the technique, feasibility, and results of transperineal MFGB under local anesthesia, in an ambulatory setting without the administration of prophylactic antibiotics. DESIGN, SETTING, AND PARTICIPANTS: This single-center study enrolled consecutive biopsy-naïve men with a clinical suspicion of prostate cancer into a prospective database between November 2015 and November 2020. Men with Prostate Imaging Reporting and Data System (PI-RADS) version 2 scores 3-5 underwent transperineal MFGB. SURGICAL PROCEDURE: Transperineal MFGB was performed in an ambulatory setting under local anesthesia by a single operator. MEASUREMENTS: Procedure-associated adverse events were recorded. Patient discomfort during both the local anesthesia and the biopsy procedure was determined using a visual analogic scale (0-10). Detection rates of grade group (GG) ≥2 prostate cancer and the proportion of men with GG 1 cancer were assessed. RESULTS AND LIMITATIONS: A total of 1097 eligible men underwent transperineal MFGB. The complication rate was 0.73% (8/1097); complications comprised five (0.46%) urinary tract infections including one hospitalization and three (0.27%) urinary retentions. In 735 men, the median pain scores were 2 (interquartile range [IQR] 2-3) for the local anesthesia procedure and 1 (IQR 0-2) for the biopsy. Prostate cancer was detected in 84% (926/1097) of men; 66% (723/1097) had GG ≥2 and 19% (203/1097) GG 1. CONCLUSIONS: Transperineal MFGB can safely be performed as an outpatient procedure under local anesthesia in an ambulatory setting. The detection rate of clinically significant prostate cancer is high, and biopsy is well tolerated. Although no antibiotic prophylaxis was used, the rate of infectious complications is practicably negligible. PATIENT SUMMARY: This article shows how tissue samples (biopsies) can accurately be obtained from suspicious regions seen on prostate magnetic resonance imaging via needles inserted in the perineum (skin between the scrotum and the anus) in men with suspected prostate cancer. This technique appears to be very well tolerated under local anesthesia and has a lower risk of infection without antibiotic prophylaxis than the more common biopsy route through the rectum, with antibiotics.
引用
- Immerzeel J, Israël B, Bomers J, et al. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia. Eur Urol. 2021. PMID: 34799197. doi:10.1016/j.eururo.2021.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。